The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless goods represents a substantial regulatory challenge with the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is known to act as a sedative at significant dosages6. The promises created by Nicotine River, ECBlend, and also other vendors th